U.S. Could Do More Nvidia-Style Deals Taking a Cut of Revenue, Bessent Says
'I think we could see it in other industries over time. I think right now this is unique, but now that we have the model, and the beta test, why not expand it?' he said in an interview with Bloomberg TV Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
30 minutes ago
- Forbes
3 Part-Time Remote Jobs That Pay Up To $60+/Hr In 2025
The average U.S. salary for a 40-hour working week is $62,191; but you can make this figure and even more without working full time or putting in crazy hours. You can: Or you could: And you could see earnings of $60 to even $3,000 per hour (for example, as a keynote speaker). In this article, you'll learn about a few of the best three part-time remote jobs are hiring right now. They only take a few hours or a couple days each week, so they won't consume your every waking minute. And these remote part-time jobs enable you to make the most money in the least amount of time, which means you have more freedom and flexibility to do other things, like spend time with family, start your dream business, or invest in professional development for your career. 3 Part-Time Remote Jobs That Pay Up To $50/Hr The part-time roles below may allow you to work part-time hours through the week and weekends, or the employer may request you to work full-time for only two or three days a week. Both options count as full-time, and it's up to you to negotiate and find the right employer and vacancy that fits your personal needs and works around your lifestyle. This is your moment to seize freedom and flexibility. With high demand and strong career projections for each of these remote roles, 2025 is your chance to break away from the rat race, define your working hours around your lifestyle, and enjoy your job instead of grinding to the point of burnout every day. If you found this article helpful, you'll definitely want to read this next: 18 High-Paying, Part-Time Remote Jobs For Freelancers.
Yahoo
an hour ago
- Yahoo
Here's The Share of Gold or Crypto Ray Dalio Says Investors Should Hold
In light of the United States' precarious fiscal situation, Ray Dalio, the founder of Bridgewater Associates, has advised investors to consider dedicating approximately 15% of their portfolio to either gold or Bitcoin. What Happened: In a recent interview, Dalio expressed his apprehension about a looming US debt crisis. He pointed out that the US dollar is being undermined due to excessive borrowing and deficit spending, leading to currency debasement. 'If you were neutral on everything and optimizing your portfolio for the best return-to-risk ratio, you would have about 15% of your money in gold or Bitcoin,' Dalio stated. Dalio also emphasized the need for effective diversification in a portfolio, recommending allocating about 15% as a protective hedge. During the discussion, he clarified that although he has a preference for gold over Bitcoin, the real economic issue is the devaluation of fiat money, which is currently affecting markets and investors. Also Read: Ray Dalio Shares Crucial Investment Advice for Those Who Want to Invest Well While some financial experts advocate for a higher allocation towards crypto, Dalio's balanced approach aligns with his brand. Dalio's recommendation comes at a time when the US is grappling with a burgeoning debt crisis. The rapid borrowing and deficit spending by the government are causing a devaluation of the US dollar, which is impacting markets and investors. By suggesting a 15% portfolio allocation to gold or bitcoin, Dalio is offering a potential solution for investors to safeguard their investments against the devaluation of fiat money. While some experts suggest a higher allocation to crypto, Dalio's measured approach provides a balanced perspective. It offers investors a solid foundation to profit in unexpected circumstances, thereby mitigating the risks associated with the current economic situation. Read Next Ray Dalio's Timeless Stock Market Advice: 'Don't Try to Time the Market Yourself Because You'll Probably Lose' Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Here's The Share of Gold or Crypto Ray Dalio Says Investors Should Hold originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Tempus AI (TEM) Raises Full-Year Revenue Guidance
Tempus AI has posted an impressive price move of 21% over the last week, likely influenced by a blend of recent developments. The company announced significant revenue growth in its second quarter results and notably reduced its net loss. This positive financial performance was reinforced by the raised full-year revenue guidance, although it accompanies challenges such as a class action lawsuit and a substantial equity offering. The broader market has also been on an upward trajectory, with the Dow reaching records, which may have contributed to buoying Tempus AI's stock amidst mixed news on legal and financial fronts. We've discovered 3 warning signs for Tempus AI that you should be aware of before investing here. We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Tempus AI's recent developments, including significant revenue growth and reduced net loss for the second quarter, have influenced its impressive 21% share price increase over the last week. Over the longer period of the past year, the company's total return was 45.01%, showcasing substantial growth compared to both the broader market and its industry peers. Tempus AI outpaced the US Life Sciences industry, which had a return of -19.8%, and also exceeded the US market's 17% return. These positive financial results reinforce the company's revenue and earnings forecasts, supported by strong testing volumes and strategic biopharma partnerships. Analysts have projected Tempus AI's revenue to grow by 29.8% annually over the next three years, even though profitability remains elusive in the short term. The raised full-year revenue guidance could further bolster future earnings, provided reimbursement and regulatory challenges are effectively managed. Despite the current share price of $73.78, slightly above the consensus analyst price target of $70.0, the company's rapid growth trajectory potentially justifies this premium. Analysts' expectations reflect a degree of agreement regarding Tempus AI's valuation, suggesting that the stock may be fairly priced. However, sustained momentum in revenue, coupled with disciplined cost management, will be crucial for aligning with long-term growth objectives and closing any gaps between market performance and valuation targets. Our comprehensive valuation report raises the possibility that Tempus AI is priced higher than what may be justified by its financials. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TEM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
